Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
- Products
-
- Lisdexamfetamine Dimesylate Capsules
- Company
- Lannett Company Inc.
- Where it was sold
-
Nationwide within the USA
Nationwide
- Units affected
- 8544 bottles
- About this recall
- Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37